Volume: February 2024, Issue 1

Feb 29, 2024 | Hot Topics

AARS News

  • Register now for the 17th Annual AARS Networking Reception
  • Register now for the 11th Annual AARS Scientific Symposium
  • AARS Call for Grant Applications
  • AARS Reacts to Acne Treatment Guidelines

New Medical Research

  • Prevalence of acne and its impact on quality of life and practices regarding self-treatment among medical students.
  • Efficacy of spironolactone compared with doxycycline in moderate acne in adult females: Results of the multicentre, controlled, randomized, double-blind prospective and parallel female acne spironolactone vs doxycycline efficacy (FASCE) study.
  • Very low-calorie ketogenic diet (VLCKD) in the management of hidradenitis suppurativa (Acne Inversa): an effective and safe tool for improvement of the clinical severity of disease. Results of a pilot study.
  • IPL-PDT as an effective treatment for mild-to-moderate acne vulgaris: A prospective, single-center, self-controlled study.
  • Sarecycline improves acne severity, symptoms, and psychosocial burden in non-nodular acne vulgaris: PROSES study.
  • Impact of acne vulgaris and sarecycline on social/emotional functioning and daily activities: PROSES Study.
  • Assessing the impact of acne and its treatment on disease burden and quality of life.
  • Antibiotic Stewardship in Acne: 2023 Update.
  • Benefit of topical combination therapy for acne: Analyzing effect size using number needed to treat.
  • New insights into systemic drivers of inflammation and their contributions to the pathophysiology of acne.

Clinical Reviews

  • Microencapsulated benzoyl peroxide for rosacea in context: A review of the current treatment landscape.
  • Acne treatment challenges – Recommendations of Latin American expert consensus.
  • The role of botulinum neurotoxin BoNT-A in the management of oily skin and acne vulgaris: A comprehensive review.
  • The impact of current investigational drugs for acne on future treatment strategies.
  • Deciphering childhood rosacea: A comprehensive review.
  • A network meta-analysis to explore the effectiveness of the different treatment modalities in acne scars.
  • Modern techniques in addressing facial acne scars: A thorough analysis.
  • Use of oral supplements and topical adjuvants for isotretinoin-associated side effects: A narrative review.
  • Review of scoring systems for hidradenitis suppurativa.

Related Posts

Volume: July 2024, Issue 1

Volume: July 2024, Issue 1

AARS News AARS July Membership Discount Available to HCPs Amid Paucity of Innovation, New Acne Treatment Guidelines Overlook Critical Issues: Editorial AARS Spotlights #AcneFacts During National Acne Awareness Month AARS Goes One-on-One with Dermatologist Sandra Lee,...

Volume: June 2024, Issue 1

Volume: June 2024, Issue 1

AARS News   Highlights from the 11th Annual AARS Annual Scientific Symposium New Medical Research Isotretinoin for acne in transgender and gender-diverse individuals receiving masculinizing hormone therapy. Efficacy and safety of bimekizumab in patients with...

Volume: May 2024, Issue 1

Volume: May 2024, Issue 1

AARS News   AARS Call for Grant Applications New Medical Research Triple combination clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% for acne: Efficacy and safety from a pooled phase 3 analysis. The role of vitamins and nutrients in rosacea....

Volume: July 2024, Issue 1

Volume: April 2024, Issue 1

AARS News   Register now for the 11th Annual AARS Scientific Symposium AARS Call for Grant Applications Response Statement from the American Acne & Rosacea Society to the Valisure Citizen Petition on Benzene in Benzoyl Peroxide Drug Products New Medical...